Bluejay Diagnostics, Inc.
BJDX- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001704287
In the last 90 days, Bluejay Diagnostics, Inc. insiders filed 1 open-market purchase and 1 sale; 8 institutions reported holding it in 13F filings for Q2 2026, worth $259.3K in total; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding Bluejay Diagnostics, Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 9 | 5 | −4 |
| Shares | 428.6K | 169.5K | −259.1K (−60.4%) |
| Value | $344.7K | $118.6K | −$226.1K (−65.6%) |
New holders (3)
Institutions that held Bluejay Diagnostics, Inc. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Anson Funds Management LP | 69,510 | $48.6K | 0.01% |
| CVI Holdings, LLC | 66,165 | $46.3K | 0.04% |
| Warberg Asset Management LLC | 12,500 | $8.74K | 0.00% |
Sold out (7)
Institutions that held Bluejay Diagnostics, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Sabby Management, LLC | 187,293 | $150.4K |
| Armistice Capital, LLC | 176,000 | $141.3K |
| Citadel Advisors LLC | 19,853 | $15.9K |
| Renaissance Technologies LLC | 17,100 | $14.0K |
| XTX Topco Ltd | 10,534 | $8.43K |
| Advisor Group Holdings, Inc. | 25 | $20 |
| Wells Fargo & Company | 10 | $8 |